Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Small-Vessel Pixel Stent Receives Alloy Upgrade In Next Generation – Guidant

This article was originally published in The Gray Sheet

Executive Summary

Guidant expects FDA approval of its next-generation Pixel stent for small vessels within the coming weeks

You may also be interested in...



Boston Scientific Liberty Stent Groomed To Face Next-Gen Cobalt Competitors

Boston Scientific will enroll approximately 400 patients in an ongoing clinical trial to support a PMA supplement for the firm's Taxus Liberty stent platform

Boston Scientific Liberty Stent Groomed To Face Next-Gen Cobalt Competitors

Boston Scientific will enroll approximately 400 patients in an ongoing clinical trial to support a PMA supplement for the firm's Taxus Liberty stent platform

Stenting In Heart Attack Patients Cleared By FDA; Guidant’s Multi-Link Is First

Guidant is now the only company with a coronary stent indicated for use in heart attack patients in the U.S. The firm announced Aug. 14 that the Multi-Link stent platform received FDA approval via PMA supplement

Latest Headlines
See All
UsernamePublicRestriction

Register

MT018643

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel